Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07864311
PHASE1

A Phase 1 Study of VELA-101 in Adult Participants

Sponsor: Ursa Medicines

View on ClinicalTrials.gov

Summary

This is a first-in-human (FIH), multicenter, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of VELA-101, following single-ascending doses via subcutaneous (SC) administration.

Official title: A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VELA-101 in Adult Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-11

Completion Date

2027-09

Last Updated

2026-10-07

Healthy Volunteers

Yes

Interventions

DRUG

VELA-101

subcutaneous injection

DRUG

Placebo

subcutaneous injection

Locations (2)

University of Sunshine Coast

Morayfield, Queensland, Australia

Linear Clinical Research

Nedlands, Western Australia, Australia